BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11680784)

  • 1. Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins.
    Just I; Hofmann F; Genth H; Gerhard R
    Int J Med Microbiol; 2001 Sep; 291(4):243-50. PubMed ID: 11680784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile.
    Just I; Selzer J; von Eichel-Streiber C; Aktories K
    J Clin Invest; 1995 Mar; 95(3):1026-31. PubMed ID: 7883950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
    Genth H; Dreger SC; Huelsenbeck J; Just I
    Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A.
    Schoentaube J; Olling A; Tatge H; Just I; Gerhard R
    Cell Microbiol; 2009 Dec; 11(12):1816-26. PubMed ID: 19709124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho GTPases as targets of bacterial protein toxins.
    Aktories K; Schmidt G; Just I
    Biol Chem; 2000; 381(5-6):421-6. PubMed ID: 10937872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.
    Huelsenbeck J; Dreger SC; Gerhard R; Fritz G; Just I; Genth H
    Biochemistry; 2007 Apr; 46(16):4923-31. PubMed ID: 17397186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling.
    Sehr P; Joseph G; Genth H; Just I; Pick E; Aktories K
    Biochemistry; 1998 Apr; 37(15):5296-304. PubMed ID: 9548761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation by rho family GTPases of IL-1 receptor induced signaling: C3-like chimeric toxin and Clostridium difficile toxin B inhibit signaling pathways involved in IL-2 gene expression.
    Dreikhausen U; Varga G; Hofmann F; Barth H; Aktories K; Resch K; Szamel M
    Eur J Immunol; 2001 May; 31(5):1610-9. PubMed ID: 11465119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cytokinesis by Clostridium difficile toxin B and cytotoxic necrotizing factors--reinforcing the critical role of RhoA in cytokinesis.
    Huelsenbeck SC; May M; Schmidt G; Genth H
    Cell Motil Cytoskeleton; 2009 Nov; 66(11):967-75. PubMed ID: 19504561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of MMP-2 by Clostridium difficile toxin B in bovine smooth muscle cells.
    Koike T; Kuzuya M; Asai T; Kanda S; Cheng XW; Watanabe K; Banno Y; Nozawa Y; Iguchi A
    Biochem Biophys Res Commun; 2000 Oct; 277(1):43-6. PubMed ID: 11027636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucosylation of Rho proteins by Clostridium difficile toxin B.
    Just I; Selzer J; Wilm M; von Eichel-Streiber C; Mann M; Aktories K
    Nature; 1995 Jun; 375(6531):500-3. PubMed ID: 7777059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super toxins from a super bug: structure and function of Clostridium difficile toxins.
    Davies AH; Roberts AK; Shone CC; Acharya KR
    Biochem J; 2011 Jun; 436(3):517-26. PubMed ID: 21615333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B.
    Genth H; Huelsenbeck J; Hartmann B; Hofmann F; Just I; Gerhard R
    FEBS Lett; 2006 Jun; 580(14):3565-9. PubMed ID: 16730714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
    Jank T; Aktories K
    Trends Microbiol; 2008 May; 16(5):222-9. PubMed ID: 18394902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile toxins attack Rho.
    Wilkins TD; Lyerly DM
    Trends Microbiol; 1996 Feb; 4(2):49-51. PubMed ID: 8820565
    [No Abstract]   [Full Text] [Related]  

  • 17. Large clostridial cytotoxins.
    Just I; Gerhard R
    Rev Physiol Biochem Pharmacol; 2004; 152():23-47. PubMed ID: 15449191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile toxins: mechanism of action and role in disease.
    Voth DE; Ballard JD
    Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins.
    Schirmer J; Aktories K
    Biochim Biophys Acta; 2004 Jul; 1673(1-2):66-74. PubMed ID: 15238250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin.
    Giry M; Popoff MR; von Eichel-Streiber C; Boquet P
    Infect Immun; 1995 Oct; 63(10):4063-71. PubMed ID: 7558320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.